Neurodegenerative diseases and effective drug delivery: A review of challenges and novel therapeutics.
Blood brain barrier
Brain targeted drug delivery
Injectable
Nanotechnology
Neurodegenerative diseases
Polymer implants
Stem cells
Journal
Journal of controlled release : official journal of the Controlled Release Society
ISSN: 1873-4995
Titre abrégé: J Control Release
Pays: Netherlands
ID NLM: 8607908
Informations de publication
Date de publication:
10 02 2021
10 02 2021
Historique:
received:
30
06
2020
revised:
11
11
2020
accepted:
11
11
2020
pubmed:
17
11
2020
medline:
8
7
2021
entrez:
16
11
2020
Statut:
ppublish
Résumé
The central nervous system (CNS) encompasses the brain and spinal cord and is considered the processing center and the most vital part of human body. The central nervous system (CNS) barriers are crucial interfaces between the CNS and the periphery. Among all these biological barriers, the blood-brain barrier (BBB) strongly impede hurdle for drug transport to brain. It is a semi-permeable diffusion barrier against the noxious chemicals and harmful substances present in the blood stream and regulates the nutrients delivery to the brain for its proper functioning. Neurological diseases owing to the existence of the BBB and the blood-spinal cord barrier have been terrible and threatening challenges all over the world and can rarely be directly mediated. In fact, drug delivery to brain remained a challenge in the treatment of neurodegenerative (ND) disorders, for these different approaches have been proposed. Nano-fabricated smart drug delivery systems and implantable drug loaded biomaterials for brain repair are among some of these latest approaches. In current review, modern approaches developed to deal with the challenges associated with transporting drugs to the CNS are included. Recent studies on neural drug discovery and injectable hydrogels provide a potential new treatment option for neurological disorders. Moreover, induced pluripotent stem cells used to model ND diseases are discussed to evaluate drug efficacy. These protocols and recent developments will enable discovery of more effective drug delivery systems for brain.
Identifiants
pubmed: 33197487
pii: S0168-3659(20)30670-2
doi: 10.1016/j.jconrel.2020.11.021
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1152-1167Informations de copyright
Copyright © 2020. Published by Elsevier B.V.